Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 4
2011 2
2012 2
2013 5
2014 8
2015 11
2016 18
2017 13
2018 11
2019 13
2020 15
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32111657

84 results
Results by year
Filters applied: . Clear all
Page 1
Occurrence of the Redifferentiation-Akin Phenomenon on 68Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation?
Sharma P, Basu S. Sharma P, et al. J Nucl Med Technol. 2020 Sep;48(3):290-291. doi: 10.2967/jnmt.120.241539. Epub 2020 Feb 28. J Nucl Med Technol. 2020. PMID: 32111657 Review.
MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with 68Ga-DOTATATE and 18F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting.
Sampathirao N, Basu S. Sampathirao N, et al. J Nucl Med Technol. 2017 Mar;45(1):34-41. doi: 10.2967/jnmt.116.185777. Epub 2017 Feb 2. J Nucl Med Technol. 2017. PMID: 28154019 Free article.
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, Caplin ME. Wild D, et al. J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7. J Nucl Med. 2013. PMID: 23297077 Free article. Clinical Trial.
Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E, Alshammari A, Michopoulou S, Skoura E, Naik K, Maragkoudakis E, Mohmaduvesh M, Al-Harbi M, Belda M, Caplin ME, Toumpanakis C, Bomanji J. Panagiotidis E, et al. J Nucl Med. 2017 Jan;58(1):91-96. doi: 10.2967/jnumed.116.178095. Epub 2016 Aug 11. J Nucl Med. 2017. PMID: 27516446 Free article.
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.
Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C, Almukhailed O, Kayani I, Syed R, Navalkissoor S, Ell PJ, Caplin ME, Bomanji J. Skoura E, et al. J Nucl Med. 2016 Jan;57(1):34-40. doi: 10.2967/jnumed.115.166017. Epub 2015 Oct 15. J Nucl Med. 2016. PMID: 26471695 Free article.
111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden.
Hope TA, Calais J, Zhang L, Dieckmann W, Millo C. Hope TA, et al. J Nucl Med. 2019 Sep;60(9):1266-1269. doi: 10.2967/jnumed.118.223016. Epub 2019 Mar 8. J Nucl Med. 2019. PMID: 30850506 Free PMC article. Clinical Trial.
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
You H, Kandathil A, Beg M, De Blanche L, Kazmi S, Subramaniam RM. You H, et al. Nucl Med Commun. 2020 Oct;41(10):1060-1065. doi: 10.1097/MNM.0000000000001255. Nucl Med Commun. 2020. PMID: 32732600
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
Velikyan I, Sundin A, Sörensen J, Lubberink M, Sandström M, Garske-Román U, Lundqvist H, Granberg D, Eriksson B. Velikyan I, et al. J Nucl Med. 2014 Feb;55(2):204-10. doi: 10.2967/jnumed.113.126177. Epub 2013 Dec 30. J Nucl Med. 2014. PMID: 24379222 Free article. Clinical Trial.
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback